Providence First Trust
BIIB icon

Providence First Trust’s Biogen BIIB Stock Holding History

Providence First Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06M Buy
4,697
+522
+13% +$111K 0.35% 76
2026
Q2 		$902K Buy
4,175
+1,096
+36% +$210K 0.25% 107
2026
Q1 		$564K Buy
+3,079
New +$567K 0.2% 111

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Providence First Trust's BIIB Position: Q3 2026 in Review

Providence First Trust increased its Biogen (BIIB) stake by 13% in Q3 2026, buying an estimated $111K and bringing the position to 4,697 shares worth $1.06M. The position accounts for 0.35% of the portfolio, ranked #76.

Providence First Trust first reported a position in BIIB in Q1 2026 and has held it in 3 quarters since. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Providence First Trust held 4,697 shares of Biogen worth $1.06M as of Q3 2026.
  • Providence First Trust bought 522 Biogen shares in Q3 2026, an estimated $111K.
  • Biogen made up 0.35% of Providence First Trust's portfolio in Q3 2026, its #76 holding.
  • Providence First Trust first reported a position in Biogen in Q1 2026 and has held it in 3 quarters since.
  • 643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Providence First Trust's 13F filing for Q3 2026, filed 2 Nov 2026.